Home › Ovarian Epithelial Carcinoma › Texas
Ovarian Epithelial Carcinoma clinical trials in Texas
12 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Texas.
Cities in Texas
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Texas Oncology - Austin Central /ID# 275046, Austin
- Texas Oncology - Fort Worth Cancer Center /ID# 275043, Fort Worth
- Houston Methodist Hospital /ID# 274568, Houston
- and 3 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Dallas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UT Southwestern Medical Center, Dallas
- DHR Health Advance Care Center, Edinburg
- The Center for Cancer and Blood Disorders, Forth Worth
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, San Antonio
- Research Site, Tyler
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Jun 23, 2026 · NCT07432633CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0103, Houston
RecruitingPhase 1
Ages 18 and older · Women · Updated Apr 7, 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- SCRI - Texas Oncology, Fort Worth
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775A Study of NX-1607 in Adults With Advanced Malignancies
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542BP1001-A in Patients With Advanced or Recurrent Solid Tumors
- Mary Crowley Cancer Research, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 7, 2025 · NCT04196257From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.